• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肥胖和糖尿病对肝细胞癌风险的影响。

The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.

作者信息

Polesel J, Zucchetto A, Montella M, Dal Maso L, Crispo A, La Vecchia C, Serraino D, Franceschi S, Talamini R

机构信息

S.O.C. Epidemiologia e Biostatistica, IRCCS, Centro di Riferimento Oncologico, Aviano, Pordenone, Italy.

出版信息

Ann Oncol. 2009 Feb;20(2):353-7. doi: 10.1093/annonc/mdn565. Epub 2008 Aug 22.

DOI:10.1093/annonc/mdn565
PMID:18723550
Abstract

BACKGROUND

Obesity has been associated to increased hepatocellular carcinoma (HCC) risk, but studies on the topic do not fully account for hepatitis B virus (HBV) and hepatitis C virus (HCV) infections. Likewise, an increased risk has been reported for diabetes mellitus (DM) but whether DM is an independent risk factor has not been established yet. To evaluate the association of obesity and DM with HCC risk, we conducted a hospital-based, case-control study in two Italian areas.

PATIENTS AND METHODS

From 1999 to 2003, 185 HCC cases and 404 hospital controls were enrolled. Blood samples were obtained for HBV and HCV screening.

RESULTS

After allowance for known risk factors, body mass index >/=30 kg/m(2) [odds ratio (OR) = 1.9, 95% confidence interval (CI) 0.9-3.9] and DM (OR = 3.7, 95% CI 1.7-8.4) were associated to HCC risk. These associations persisted (OR = 3.5, 95% CI 1.6-7.7 for obesity; OR = 3.5, 95% CI 1.3-9.2 for DM) among subjects without HBV and/or HCV infection. Overall, 23% of HCC cases seemed attributable to these conditions, and this figure rose to 37% among subjects without HBV and/or HCV infections.

CONCLUSIONS

The present study provides further evidence that obesity and DM increase HCC risk and that these factors may explain a relevant proportion of cases among subjects without markers of HBV/HCV infection.

摘要

背景

肥胖与肝细胞癌(HCC)风险增加有关,但关于该主题的研究并未充分考虑乙型肝炎病毒(HBV)和丙型肝炎病毒(HCV)感染情况。同样,糖尿病(DM)的风险也有所增加,但DM是否为独立风险因素尚未确定。为评估肥胖和DM与HCC风险的关联,我们在意大利的两个地区开展了一项基于医院的病例对照研究。

患者与方法

1999年至2003年,共纳入185例HCC病例和404例医院对照。采集血样进行HBV和HCV筛查。

结果

在考虑已知风险因素后,体重指数≥30 kg/m²(比值比[OR]=1.9,95%置信区间[CI] 0.9 - 3.9)和DM(OR = 3.7,95% CI 1.7 - 8.4)与HCC风险相关。在无HBV和/或HCV感染的受试者中,这些关联依然存在(肥胖者OR = 3.5,95% CI 1.6 - 7.7;DM者OR = 3.5,95% CI 1.3 - 9.2)。总体而言,23%的HCC病例似乎可归因于这些情况,在无HBV和/或HCV感染的受试者中,这一比例升至37%。

结论

本研究进一步证明肥胖和DM会增加HCC风险,且这些因素可能解释了无HBV/HCV感染标志物受试者中相当比例的病例。

相似文献

1
The impact of obesity and diabetes mellitus on the risk of hepatocellular carcinoma.肥胖和糖尿病对肝细胞癌风险的影响。
Ann Oncol. 2009 Feb;20(2):353-7. doi: 10.1093/annonc/mdn565. Epub 2008 Aug 22.
2
A case-control study of hepatitis B and C virus infection as risk factors for hepatocellular carcinoma in Henan, China.中国河南地区乙型和丙型肝炎病毒感染作为肝细胞癌危险因素的病例对照研究。
Int J Epidemiol. 1998 Aug;27(4):574-8. doi: 10.1093/ije/27.4.574.
3
Case-control study on hepatitis C virus (HCV) as a risk factor for hepatocellular carcinoma: the role of HCV genotypes and the synergism with hepatitis B virus and alcohol. Brescia HCC Study.丙型肝炎病毒(HCV)作为肝细胞癌危险因素的病例对照研究:HCV基因型的作用以及与乙型肝炎病毒和酒精的协同作用。布雷西亚肝细胞癌研究。
Int J Cancer. 1999 May 31;81(5):695-9. doi: 10.1002/(sici)1097-0215(19990531)81:5<695::aid-ijc4>3.0.co;2-w.
4
The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans.糖尿病在肝细胞癌中的作用:一项针对美国退伍军人的病例对照研究。
Am J Gastroenterol. 2001 Aug;96(8):2462-7. doi: 10.1111/j.1572-0241.2001.04054.x.
5
Glycemic load in relation to hepatocellular carcinoma among patients with chronic hepatitis infection.慢性肝炎感染患者中血糖负荷与肝细胞癌的关系。
Ann Oncol. 2009 Oct;20(10):1741-5. doi: 10.1093/annonc/mdp059. Epub 2009 Jun 15.
6
A meta-analysis of epidemiological studies on the combined effect of hepatitis B and C virus infections in causing hepatocellular carcinoma.一项关于乙型肝炎病毒和丙型肝炎病毒感染合并导致肝细胞癌的流行病学研究的荟萃分析。
Int J Cancer. 1998 Jan 30;75(3):347-54. doi: 10.1002/(sici)1097-0215(19980130)75:3<347::aid-ijc4>3.0.co;2-2.
7
The role of previous infection of hepatitis B virus in Hbs antigen negative and anti-HCV negative Japanese patients with hepatocellular carcinoma: etiological and molecular biological study.乙型肝炎病毒既往感染在日本HBs抗原阴性及抗-HCV阴性肝细胞癌患者中的作用:病因学及分子生物学研究
J Exp Clin Cancer Res. 1999 Sep;18(3):379-89.
8
Etiological and molecular profile of hepatocellular cancer from India.印度原发性肝癌的病因和分子特征。
Int J Cancer. 2013 Jul 15;133(2):437-45. doi: 10.1002/ijc.27993. Epub 2013 Feb 13.
9
Prevalence of HBV and HCV infection in Japanese patients with hepatocellular carcinoma.日本肝细胞癌患者中乙肝病毒和丙肝病毒感染的患病率
Hepatogastroenterology. 1994 Oct;41(5):438-41.
10
Population-attributable fractions of risk factors for hepatocellular carcinoma in the United States.美国肝细胞癌风险因素的人群归因分数。
Am J Gastroenterol. 2013 Aug;108(8):1314-21. doi: 10.1038/ajg.2013.160. Epub 2013 Jun 11.

引用本文的文献

1
Hijacking homeostasis: the brain-body neural circuitry in tumor pathogenesis and emerging therapeutic frontiers.劫持体内平衡:肿瘤发病机制中的脑-体神经回路及新兴治疗前沿
Mol Cancer. 2025 Jul 25;24(1):206. doi: 10.1186/s12943-025-02396-6.
2
Role of Alcohol in Steatotic Liver Disease: Impact on Patients with Cardiometabolic Risk Factors.酒精在脂肪性肝病中的作用:对伴有心脏代谢危险因素患者的影响。
Dig Dis Sci. 2025 Mar 1. doi: 10.1007/s10620-025-08912-4.
3
Metformin: A Dual-Role Player in Cancer Treatment and Prevention.二甲双胍:癌症治疗与防治中的双重角色
Int J Mol Sci. 2024 Apr 6;25(7):4083. doi: 10.3390/ijms25074083.
4
Lenvatinib Exacerbates the Decrease in Skeletal Muscle Mass in Patients with Hepatocellular Carcinoma, Whereas Atezolizumab Plus Bevacizumab Does Not.乐伐替尼会加剧肝细胞癌患者骨骼肌质量的下降,而阿替利珠单抗联合贝伐单抗则不会。
Cancers (Basel). 2024 Jan 19;16(2):442. doi: 10.3390/cancers16020442.
5
Liver Stiffness Measurement and Risk Prediction of Hepatocellular Carcinoma After HCV Eradication in Veterans With Cirrhosis.肝硬化退伍军人 HCV 清除后肝硬度测量与肝细胞癌风险预测。
Clin Gastroenterol Hepatol. 2024 Apr;22(4):778-788.e7. doi: 10.1016/j.cgh.2023.11.020. Epub 2023 Dec 5.
6
Nonalcoholic steatohepatitis-related hepatocellular carcinoma: pathogenesis and treatment.非酒精性脂肪性肝炎相关肝细胞癌:发病机制与治疗。
Nat Rev Gastroenterol Hepatol. 2023 Aug;20(8):487-503. doi: 10.1038/s41575-023-00754-7. Epub 2023 Mar 17.
7
Diabetes and Risk of Hepatocellular Carcinoma in Cirrhosis Patients with Nonalcoholic Fatty Liver Disease.糖尿病与非酒精性脂肪性肝病合并肝硬化患者肝细胞癌风险的关系。
Gut Liver. 2023 Jan 15;17(1):24-33. doi: 10.5009/gnl220357. Epub 2022 Dec 19.
8
Estrogen receptor 1 inhibits the progression of hepatocellular carcinoma via positively regulating lncRNA maternally expressed gene 3 under high glucose conditions.在高糖条件下,雌激素受体1通过正向调控长链非编码RNA母系表达基因3抑制肝细胞癌进展。
J Gastrointest Oncol. 2022 Oct;13(5):2485-2496. doi: 10.21037/jgo-22-825.
9
Long-term cardiovascular outcomes differ across metabolic dysfunction-associated fatty liver disease subtypes among middle-aged population.代谢相关脂肪性肝病各亚型在中年人群中的长期心血管结局存在差异。
Hepatol Int. 2022 Dec;16(6):1308-1317. doi: 10.1007/s12072-022-10407-7. Epub 2022 Sep 7.
10
Viral hepatitis and hepatocellular carcinoma: From molecular pathways to the role of clinical surveillance and antiviral treatment.病毒性肝炎与肝细胞癌:从分子途径到临床监测和抗病毒治疗的作用。
World J Gastroenterol. 2022 Jun 7;28(21):2251-2281. doi: 10.3748/wjg.v28.i21.2251.